Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $379.7000 (3.44%) ($368.4400 - $384.9400) on Tue. Jan. 3, 2017. | |
| | Trend Analysis and Forecast | | | | Average Daily Percentage Swing | 2.67% (three month average) | | RSI | 44 | | Latest Price | $379.7000(3.44%) | | Stocks Behave Similarly | Similar Stock List | | Daily Trend | REGN declines -0.1% a day on average for past five trading days. | | Weekly Trend | REGN declines -0.5% a week on average for past two weeks. | | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability)
IBB(61%) XLV(49%) XBI(44%) IVW(41%) IWF(41%) | | Factors Impacting REGN price | REGN will decline at least -1.335% in a week (0% probabilities).
VIXM(-8%) UUP(-8%) TLT(-6%) TIP(-2%) SHY(-2%) | | | | | | | | Relative Volatility | (options are extremely cheap) | | | | | Market Trend Strength | -1.335% (StdDev 2.67%) | | Hourly BBV | 0 () | | Intraday Trend | 2.4% | | | | | |
|
| 5 Day Moving Average | $377.04(0.71%) | | 10 Day Moving Average | $374.84(1.3%) | | 20 Day Moving Average | $374.97(1.26%) | | To recent high | -14.6% | | To recent low | 13% | | Market Cap | $40.259b | | | | | | |
Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |